CUSIP No. 23257Y859
|
SCHEDULE 13G
|
Page 5 of 7 Pages
|
Item 1.
|
(a) Name of Issuer:
|
Cynapsus Therapeutics Inc.
|
(b) Address of Issuer’s Principal Executive Offices:
|
828 Richmond Street West
Toronto, Ontario M6J 1C9
Canada
Item 2.
|
(a) Name of Person Filing:
|
This Schedule 13G is being filed by each of the following persons (each a “Reporting Person”, and together, the “
Reporting Persons
”):
|
(i)
|
OrbiMed Capital GP V LLC (“
GP V
”)
|
|
(ii)
|
OrbiMed Advisors LLC (“
Advisors
”)
|
|
(iii)
|
Samuel D. Isaly (“
Isaly
”)
|
|
(b) Address of Principal Business Office:
|
601 Lexington Avenue, 54th Floor
New York, NY 10022
Please refer to Item 4 on each cover sheet for each filing person.
|
(d) Title of Class of Securities:
|
Common Stock
23257Y859
CUSIP No. 23257Y859
|
SCHEDULE 13G
|
Page 6 of 7 Pages
|
Item 3.
Not Applicable
Item 4. Ownership:
GP V is the sole general partner of OrbiMed Private Investments V, LP (“
OPI V
”), which holds 816,154 shares of the Issuer’s Common Stock (“
Shares
”). Advisors is an investment advisor in accordance with § 240.13d-1(b)(1)(ii)(E) and is the Managing Member of GP V. Isaly is the Managing Member of Advisors and a control person in accordance with § 240.13d-1(b)(1)(ii)(G). On the basis of these relationships, GP V, Advisors and Isaly may be deemed to share beneficial ownership of the Shares held by OPI V.
|
(a)
|
Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
|
|
(b)
|
Percent of class: See the response(s) to Item 11 on the attached cover page(s).
|
|
(c)
|
Number of shares as to which such person has:
|
(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
.
See Item 4.
Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the
Parent Holding Company or Control Person.
Not Applicable.
Item 8. Identification and Classification of Members of the Group
.
Not Applicable.
Item 9. Notice of Dissolution of Group
.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP No. 23257Y859
|
SCHEDULE 13G
|
Page 7 of 7 Pages
|
SIGNATURE
S
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: September 16, 2016
|
OrbiMed Capital GP V LLC
By: OrbiMed Advisors LLC, its Managing Member
|
|
|
|
|
|
|
By:
|
/s/ Samuel D. Isaly
|
|
|
|
Name:
|
Samuel D. Isaly
|
|
|
|
Title:
|
Managing Member
|
|
|
|
|
|
|
|
|
|
|
OrbiMed Advisors LLC
|
|
|
|
|
|
|
|
By:
|
/s/ Samuel D. Isaly
|
|
|
|
Name:
|
Samuel D. Isaly
|
|
|
|
Title:
|
Managing Member
|
|
|
|
|
|
|
|
Samuel D. Isaly
|
|
|
|
|
|
|
|
/s/ Samuel D. Isaly
|
|
|
|
Name:
|
Samuel D. Isaly
|
|